Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > sesn will be meeeting with the fda on march 23 yes?..

<< Previous

Bullboard Posts

Next >>

Post by floatinketuckyon Mar 08, 2022 7:20am

235 Views

Post# 34494007

sesn will be meeeting with the fda on march 23 yes?..

They are dong a news push prior.

They are still not PIV 2b BTD AA

The FDA will most likely let them walk the plank if they choose.

they will be partying on the plank...

with bad wood... and data

JMO

#after the engine blows sponser ship stickers...

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?